Trial NCT02236572

View at ClinicalTrials.gov 
Org. Study IDs: 1405013982

Last trial update was posted on 2022-02-01

MeSH Interventions

Everolimus

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

Phase 2 of recruitment was contingent on 5 of 15 patients responding, which did not occur.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID